Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olistica Life Sciences Group is a botanical science and technology company dedicated to the research, development, and production of pharmaceutical-grade botanical drug substances. The company specializes in the extraction and purification of cannabinoids and other plant-derived molecules, utilizing a proprietary technology platform to ensure high purity and standardization. Olistica's pipeline focuses on therapeutic areas such as chronic pain, inflammatory diseases, and neurological conditions, aiming to bridge the gap between traditional botanical medicine and modern clinical standards. Their business model includes both internal drug development and the supply of standardized botanical ingredients to other pharmaceutical and research organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olistica.